|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Inhibition of mutated, activated BRAF in metastatic melanoma 显示文摘 | Flaherty KT Puzanov I Kim KB | 2010 | N Engl J Med2010，363，9： | 1 |
| 2 | Inhibition of mutated,activated BRAF in metastatic melanoma显示文摘 | FLAHERTY K T PUZANOV I KIM K B | | 0，，09： | 1 |
| 3 | Inhibition of mutated,activated BRAF in metastatic melanoma 显示文摘 | Flaherty K T Puzanov I Kim K B | 2010 | N Engl J Med2010，363，9： | 1 |
| 4 | Effects of pharmaceuticals on Daphnia survival, growth, and reproduction显示文摘 | Flaherty C M Dodson S I | 2005 | Chemosphere2005，61，2： | 1 |
| 5 | Identification of benzimidazole-based inhibitors of the mitogen activated kinase-5 signaling pathway显示文摘 | Flaherty PT Chopra I Jain P | 2010 | Bioorg Med Chem Lett2010，20，9： | 1 |
| 6 | Phase Ⅰ study of PLX4032: Proof of concept for V600E BRAF mutation as a therapeutic target in human cancer 显示文摘 | Puzanov J Sosman K Flaherty I | 2009 | J Clin Oncol2009，27，15： | 1 |
| 7 | Inhibition of mu-tated, activated BRAF in metastatic melanoma 显示文摘 | Flaherty K T Puzanov I Kim K B | 2010 | New Engl J Med2010，363，9： | 1 |
| 8 | Metabolic control and quality-of-life self-assessment in adolescents with IDDM显示文摘 | Guttmann-Bauman I Flaherty BP Strugger M | 1998 | Diabetes Care1998，21，6： | 1 |
| 9 | Inhibition of mutated,activated BRAF in metastatic melanoma 显示文摘 | Flaherty KT Puzanov I Kim KB | 2010 | N Engl J Med2010，363，9： | 1 |
| 10 | Effects of pharmaceuticals on Daphnia survival, growth, and reproduction 显示文摘 | Flaherty C M Dodson S I | 2005 | Chemosphere2005，61，2： | 1 |
| 11 | Inhibition of mutated,acti rated BRAF in metastatic melanoma显示文摘 | Flaherty K T Puzanov I Kim K B | 2010 | N Engi J Med2010，363，9： | 1 |
| 12 | Inhibition of mu- tated,activated BRAF in metastatic melanoma 显示文摘 | Flaherty KT Puzanov I Kim KB | 2010 | N Engl J Med2010，363，9： | 1 |
| 13 | Inhibition of Mutated, Activated BRAF in Metastatic Melanoma 显示文摘 | Flaherty KT Puzanov I Kim KB | 2010 | N Eng J Med2010，363，4： | 1 |
| 14 | Inhibition of mutated, acti-vated BRAF in metastatic melanoma 显示文摘 | Flaherty KT Puzanov I Kim KB | 2010 | N Engl J Med2010，363，9： | 1 |
| 15 | Effects of pharmaceuticals on Daphnia survival,growth,and reproduction显示文摘 | Flaherty C M Dodson S I | | 0，，02： | 1 |
| 16 | Remarkable decline in isehernic stroke mortality is not matched by changes in incidence显示文摘 | Vaartjes I O'Flaherty M Capewell S | 2013 | Stroke2013，44，3： | 1 |
| 17 | Phase Ⅰ study of PLX4032 : Proof of concept for V600E BRAF mutation as a therapeutic target in human cancer 显示文摘 | Flaherty K Puzanov I Sosman J | 2009 | J Clin Oncol2009，27，15： | 1 |
| 18 | Inhibition of mutated, activated BRAF in metastatic melanoma 显示文摘 | Flaherty KT Puzanov I Kim KB | 2010 | N Engl J Med2010，363，9： | 1 |
| 19 | Inhibition of mutated, activated BRAF in metastatic melanoma显示文摘 | Flaherty KT Puzanov I Kim KB | 2010 | N Engl J Med2010，363，9： | 1 |
| 20 | Defi- ning hematoma expansion in intracerebral hemorrhage relationship with patient outeomes显示文摘 | I)owlatshahi D Demehuk AM Flaherty ML | 2011 | Neurology2011，76，14： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员